Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
COVID-19 |
Free Subscription
1 Ann Intern Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO COVID-19 is free of charge.
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination
Campaigns in the United States.
Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
PubMed
Abstract available
Preclinical animal models to evaluate therapeutic antiviral antibodies.
Antiviral Res. 2024 Mar 26:105843. doi: 10.1016/j.antiviral.2024.105843.
PubMed
Abstract available
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor
N-0385 and synergistic action with direct-acting antivirals.
Antiviral Res. 2024 Mar 26:105869. doi: 10.1016/j.antiviral.2024.105869.
PubMed
Abstract available
Covid-19: Pfizer vaccine to be available privately at pharmacy chain Boots from
April.
BMJ. 2024;384:q762.
PubMed
Covid remembered in NHS portraits.
BMJ. 2024;384:q741.
PubMed
Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A
Multinational, Controlled Case-Ascertained Prospective Study.
Clin Infect Dis. 2024 Mar 26:ciae069. doi: 10.1093.
PubMed
Abstract available
Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water,
Thailand, 2021.
Emerg Infect Dis. 2024;30:791-794.
PubMed
Abstract available
Opportunistic Elizabethkingia miricola Infections in Intensive Care Unit, Spain.
Emerg Infect Dis. 2024;30:834-837.
PubMed
Abstract available
Bus Riding as Amplification Mechanism for SARS-CoV-2 Transmission, Germany,
2021(1).
Emerg Infect Dis. 2024;30:711-720.
PubMed
Abstract available
Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19
mortality: a prospective cohort study.
Int J Infect Dis. 2024 Mar 21:107016. doi: 10.1016/j.ijid.2024.107016.
PubMed
Abstract available
Joint analysis of vaccination effectiveness and antiviral drug effectiveness for
COVID-19: a causal inference approach.
Int J Infect Dis. 2024 Mar 21:107012. doi: 10.1016/j.ijid.2024.107012.
PubMed
Abstract available
Vaccine-derived Yellow Fever in an immunocompromised patient on
anti-CD20-antibody therapy and its treatment with Sofosbuvir.
Int J Infect Dis. 2024 Mar 21:107017. doi: 10.1016/j.ijid.2024.107017.
PubMed
Abstract available
One-year outcomes in acute respiratory distress syndrome survivors: COVID-19
versus seasonal influenza or pneumonia.
Intensive Care Med. 2024 Mar 27. doi: 10.1007/s00134-024-07396.
PubMed
Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC) -
The hunt for effective treatments.
J Infect. 2024 Mar 24:106146. doi: 10.1016/j.jinf.2024.106146.
PubMed
Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in
SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose
vaccination.
J Med Virol. 2024;96:e29520.
PubMed
Abstract available
Evaluation of the effectiveness and safety of sequential vaccination with
inactivated SARS-CoV-2 vaccine and Ad5-nCoV booster in pediatric liver transplant
recipients.
J Med Virol. 2024;96:e29543.
PubMed
Abstract available
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen
signaling interplay in seasonal coronaviruses.
J Med Virol. 2024;96:e29540.
PubMed
Abstract available
CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
JAMA. 2024;331:907.
PubMed
The importance of reporting accurate estimates of long COVID prevalence.
Lancet. 2024;403:1136-1137.
PubMed
A legal mapping of 48 WHO member states' inclusion of public health emergency of
international concern, pandemic, and health emergency terminology within national
emergency legislation in responding to health emergencies.
Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
PubMed
Abstract available
Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1.
Lancet Infect Dis. 2024 Mar 21:S1473-3099(24)00155.
PubMed
Renal infarction secondary to Aspergillus spp. embolism following COVID-19.
Lancet Infect Dis. 2024;24:e266-e267.
PubMed
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing
vaccine in children in the USA: an open-label non-randomised phase 3 trial.
Lancet Infect Dis. 2024 Mar 19:S1473-3099(24)00101.
PubMed
Abstract available
The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19
vaccination in children.
Lancet Infect Dis. 2024 Mar 19:S1473-3099(24)00157.
PubMed
Global, regional, and national age-specific progress towards the 2020 milestones
of the WHO End TB Strategy: a systematic analysis for the Global Burden of
Disease Study 2021.
Lancet Infect Dis. 2024 Mar 19:S1473-3099(24)00007.
PubMed
Abstract available
Tuberculosis - United States, 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:265-270.
PubMed
Abstract available
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines
Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with
Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
PubMed
Abstract available
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in
a mouse model.
Science. 2024;383:1434-1440.
PubMed
Abstract available
Thank you for your interest in scientific medicine.